Autor: |
Elke Pucks-Faes, MD, Judith Dobesberger, MD, Lucas-Michael Halbmayer, MD, Gabriel Hitzenberger, MD, Heinrich Matzak, MD, Leopold Saltuari, MD, MSc |
Jazyk: |
angličtina |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Archives of Rehabilitation Research and Clinical Translation, Vol 2, Iss 4, Pp 100082- (2020) |
Druh dokumentu: |
article |
ISSN: |
2590-1095 |
DOI: |
10.1016/j.arrct.2020.100082 |
Popis: |
Objective: To assess the complications of dual placement of an intrathecal baclofen (ITB) pump and a ventriculoperitoneal shunt (VPS) in people with severe brain injury. Design: Case series. Setting: Referral center, ambulatory, and hospitalized care. Participants: Referred sample (N=9) composed of 5 men and 4 women with severe brain injuries (5 traumatic brain injuries, 3 subarachnoid hemorrhages, 1 intracerebral hemorrhage) and a mean disease duration of 6±4.5 years (range, 0.5-11.4y). Intervention: Both systems (ie, an ITB device and a VPS system) were implanted in all participants. Main Outcome Measures: We assessed the number and type of complications that occurred after implantation of the second system, as well as subsequent interventions. Results: The ITB delivery system was implanted after the VPS system in 5 patients (ITB group), and the VPS system was the second implanted system in 4 groups (VPS group). Seven complications occurred in 7 patients after implantation of the second system, 4 in the ITB group and 3 in the VPS group. Three of the complications were drug-related, 2 were procedure-related, and 2 were device-related. The complication occurred within 4 days after implantation of the second system in 6 patients. Conclusions: Complications are frequent in patients who undergo implantation of both an ITB delivery device and a VPS system. Drug-related complications were more common. Complications occurred more often when an ITB device was implanted as the second system. The critical period is the first 4 days. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|